ArticleWomen's health reports (New Rochelle, N.Y.)2025
Investigation of Thyroid Disorders in Women with Diabetes in the United Arab Emirates: A Retrospective Cross-Sectional Study.
Article in Women's health reports (New Rochelle, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: The present study aims to investigate thyroid disorders (TDs) in women with diabetes mellitus (DM) and the correlation, if any, between TDs and development of hypertension in this group of patients. Methods: The present study is a retrospective cross-sectional study that was conducted in the United Arab Emirates. Women with DM were randomly selected from the electronic medical records database, and 429 patients were included in the study. The investigation included age, diabetes duration, body mass index, blood pressure, hemoglobin A1c, fasting and random glucose, lipid profile, thyroid function test, and levels of thyroid-stimulating hormone. In addition, the antidiabetic medications used by patients with DM were analyzed. Results: The majority of the studied population (90%, n = 386) had type 2 DM and 33% (n = 142) had TDs; 42% participants with thyroid dysfunction had hypertension compared with 57% participants with normal thyroid function (odds ratio 0.57; 95% confidence interval 0.33-0.97; Conclusions: Two-thirds of women with DM and TDs had hypothyroidism; 42% of women with DM and TDs had hypertension. Liraglutide was seen more in patients with TDs compared with pioglitazone suggesting a potential correlation between TDs and the use of Glucagon-Like Peptide (GLP-1) analogues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.